Duopharma shares lacklustre amid EPF buying, bonus issue


Duopharma Biotech headquarters. A shareholders meeting will be held on Aug 13 to approve its bonus issue of 235.44 million shares on the basis of one bonus share or every three existing shares held.

KUALA LUMPUR: Shares of Duopharma Biotech Bhd were lacklustre in the morning session on Thursday, falling to a low of RM2.64 – the lowest since April 26.

At noon, it was trading at RM2.64, down one sen. There were 211,300 shares done at prices ranging from RM2.64 to RM2.70. It traded to a high of RM3.40 on June 1.

The FBM KLCI was up just 0.57 of a point or 0.04% to 1,491.90. Turnover was 2.75 billion shares valued at nearly RM1bil. There were 417 gainers, 343 losers and 475 counters unchanged.

The Employees Provident Fund (EPF) Board raised its shareholding to 61.08 million shares or 8.64% stake.

It bought a total of 1.64 million shares from July 26 to 30, according to filings with Bursa Malaysia.

A shareholders meeting will be held on Aug 13 to approve its bonus issue of 235.44 million shares on the basis of one bonus share or every three existing shares held.

Duopharma has received conditional registration approval from Malaysia’s Drug Control Authority (DCA) for the Covid-19 Sinopharm vaccine developed by China National Biotec Group Co Ltd.

This followed Duopharma’s application for product registration of the vaccine, which is an inactivated virus vaccine registered under the name COVILO Suspension for Injection Covid-19 Vaccine (Vero Cell).

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

   

Next In Business News

Ringgit trades lower on US asset tapering, Evergrande debt crisis
Malaysian online spending increases during 9.9 sale, says Lazada
Komark pivots into niche mask products
Quick take: BDB rises 3.4% on 30-year concession with LADA
FBM KLCI fails to extend bounce
Quick take: Tanco rises 4% in active trade
ADB lowers growth outlook for developing Asia as Covid weighs
Kenanga projects gradual recovery for KESM
Trading ideas: Southern Steel, Tanco, Bina Darulaman
China Evergrande inches close to default deadline, investors wait

Stories You'll Enjoy


Vouchers